Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Sponsor and Collaborators     

Medical University of South Carolina


Continue Reading

Contact
Alan Brisendine, CCRP     
(843) 792-9007     
[email protected]

Investigator
Melanie B. Thomas, MD     Medical University of South Carolina

ClinicalTrials.gov Identifier

NCT00881751